These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 3091241

  • 41. Is there an optimal treatment scheme for adjuvant intravesical therapy? Preliminary analysis of an EORTC protocol comparing early and delayed instillation with and without maintenance of either adriamycin or mitomycin-C in patients with superficial transitional carcinoma of the bladder.
    Kurth KH, Bouffioux C, Sylvester R, de Pauw M.
    Prog Clin Biol Res; 1988; 269():525-37. PubMed ID: 3134663
    [No Abstract] [Full Text] [Related]

  • 42. [Chemosensitivity test on superficial urinary bladder cancer using the dye exclusion assay--model of intravesical chemotherapy].
    Koseki K, Irisawa C, Shiraiwa Y.
    Nihon Hinyokika Gakkai Zasshi; 1991 Feb; 82(2):268-73. PubMed ID: 1904118
    [Abstract] [Full Text] [Related]

  • 43. The effect of intravesical instillations of thiotepa, mitomycin C, and adriamycin on normal urothelium: an experimental study in rats.
    Friedman D, Mooppan UM, Rosen Y, Kim H.
    J Urol; 1991 May; 145(5):1060-3. PubMed ID: 1901918
    [Abstract] [Full Text] [Related]

  • 44. Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
    Friedell GH.
    Cancer Chemother Pharmacol; 1983 May; 11 Suppl():S13-5. PubMed ID: 6416697
    [Abstract] [Full Text] [Related]

  • 45. Introduction and overview of intravesical therapy for superficial bladder cancer.
    Soloway MS.
    Urology; 1988 Mar; 31(3 Suppl):5-16. PubMed ID: 3126593
    [Abstract] [Full Text] [Related]

  • 46. In vitro drug sensitivity studies in human transitional cell carcinoma of the bladder.
    Konowalchuk TW, Elhilali M, Mackillop WJ.
    Cancer Lett; 1987 May; 35(2):181-90. PubMed ID: 3107798
    [Abstract] [Full Text] [Related]

  • 47. [Effects of intravesical instillation of antitumor agents on bladder cancer].
    Tomiyama T.
    Nihon Hinyokika Gakkai Zasshi; 1972 Jul; 63(7):497-518. PubMed ID: 4628074
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Intravesical chemotherapy versus immunotherapy for superficial bladder cancer.
    Huben RP.
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):17-22. PubMed ID: 8727806
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Intravesical chemotherapy. Treatment selection, techniques, and results.
    Richie JP.
    Urol Clin North Am; 1992 Aug; 19(3):521-7. PubMed ID: 1636236
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Intravesical therapy for superficial bladder cancer.
    Baselli EC, Greenberg RE.
    Oncology (Williston Park); 2000 May; 14(5):719-29; discussion 729-31, 734, 737. PubMed ID: 10853462
    [Abstract] [Full Text] [Related]

  • 57. Mitomycin C reused: an in vitro cost-effectiveness study.
    Carroll PR, Williams RD, Kim MJ, Dombrovskis S.
    J Urol; 1984 Sep; 132(3):583-6. PubMed ID: 6433045
    [Abstract] [Full Text] [Related]

  • 58. Intravesical chemotherapy for superficial carcinoma of the bladder.
    Foo KT, Tan EC, Tung KH, Tock EP.
    Singapore Med J; 1991 Dec; 32(6):420-2. PubMed ID: 1788600
    [Abstract] [Full Text] [Related]

  • 59. [In vitro clonal assay as a predictive test of sensitivity to cytostatics in carcinoma of the human bladder].
    Anton-Aparicio LM, Urmeneta J, Borras M, Balaguer R, Berián JM.
    Actas Urol Esp; 1985 Dec; 9(6):517-22. PubMed ID: 3938597
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.